Introduction
============

Renal cell carcinoma (RCC) is the most frequently occurring type of kidney cancer in adults. RCC accounts for \~3% of adult malignancies and 90--95% of neoplasms that arise from the kidney ([@b1-ol-0-0-5159]). RCC may remain clinically occult for the majority of its course, with only 10% of patients presenting to hospital with flank pain, hematuria and a flank mass, the classic triad of symptoms ([@b2-ol-0-0-5159]). The only treatment known to be effective against localized RCC is surgical resection, which may also be used for palliation in metastatic disease. Nephron-sparing surgery (NSS) refers to the complete resection of the tumor and the simultaneous effective retainment of renal tissue in order to maximize renal function ([@b3-ol-0-0-5159]). With the development of iconography and the popularity of physical examinations, the detection rate of incidental renal tumors and small renal carcinomas without symptoms has increased markedly, and increasing numbers of patients with renal tumors choose to receive NSS. Laparoscopy technology has widespread applications in urinary surgery. Laparoscopic NSS (LNSS) has become more common in the treatment of RCC and has the advantages of little trauma, quick recovery and a similar effect to open surgery ([@b4-ol-0-0-5159]). The core technologies of LNSS include controlling the warm ischemia time, guaranteeing a negative margin and avoiding the occurrence of secondary bleeding and urine leakage ([@b5-ol-0-0-5159]). Based on the constantly updated knowledge regarding renal anatomy and the anatomical structure of the nephron, certain improvements were made to the LNSS technique, which was then used to treat 31 patients with RCC in the present study. The improved LNSS achieved good clinical results.

Materials and methods
=====================

### Clinical data

A total of 56 patients, including 35 males and 21 females, who presented with RCC to the General Hospital of the People\'s Liberation Army (Beijing, China) were treated between January 2012 and November 2014. The mean age of the patients was 54.1±13.2 years, with a range of 28--68 years. All patients were indicated to possess space-occupying lesions of the kidney during the physical examinations, and were subsequently hospitalized without clinical symptoms. Prior to surgery, an ultrasound (Pro Focus 2202 Ultrasound Scanner, BK Ultrasound, Herlev, Denmark), computed tomography angiography (CTA) scan (SOMATOM^®^ Definition AS+, Siemens AG, Munich, Germany) and magnetic resonance imaging (MRI; MAGNETOM Avanto™ 3.0T, Siemens AG) examination were performed, in order to evaluate the renal vessels and location of the tumor. The average tumor size was 3.1±0.7 cm in diameter, and ranged from 1.2--4.0 cm ([Table I](#tI-ol-0-0-5159){ref-type="table"}). Pre-operative tumor-node-metastasis (TNM) staging ([@b6-ol-0-0-5159]) showed that 53 cases were T1a and 3 were T1b, including one with an anatomically solitary kidney and two with chronic renal insufficiencies. The pre-operative diagnoses were all considered to be renal tumors. The complicating diseases included 4 patients with diabetes, 2 patients with chronic renal insufficiency and 5 patients with hypertension. Routine examinations prior to the surgery revealed no surgical contraindications. In addition, a control group was studied. The control group consisted of 36 patients that received traditional partial nephrectomy surgery, which involves a sharp incision of the tumor with scissors, 5 mm from the tumor margin.

### Surgical method

All patients received LNSS under general anesthetic. Following successful anesthesia, the patients were placed in the lateral decubitus position. Trocars that were 5, 10 and 12 mm in diameter were placed 1 cm above the iliac crest in the midaxillary line, and under the 12th costal margin at the anterior and posterior axillary lines, respectively. Next, laparoscopic and surgical apparatus were implanted. The CO~2~ pressure of the pneumoperitoneum was maintained at 10.5 mm Hg H~2~O. Following the establishment of peritoneal clearance, the perirenal fascia was opened and the renal tumor was fully exposed. The renal arteries were dissociated and reattached in front of the psoas major muscle, using a Delacroix-Chevalier Gregory Bulldog clamp (115 mm; Landanger, Paris, France) to control the renal artery, and the timer was started.

Subsequent to blocking the renal artery, the renal capsule and renal cortex were incised using scissors with a ring-like shape (34310-MA-D; Karl Storz, Tuttlingen, Germany) at 3--5 mm from the tumor edge. Following the incision of the renal parenchyma, the tumor was separated from the reserved medullary and medullary ray to the depth of the basement membrane ([Fig. 1](#f1-ol-0-0-5159){ref-type="fig"}). The basal blood vessels were incised, subsequent to the hemostasis of the region using bipolar coagulation ([Fig. 2](#f2-ol-0-0-5159){ref-type="fig"}). The minor renal calyces were carefully peeled from the structure to reveal the clear anatomical structure of the wound ([Fig. 3](#f3-ol-0-0-5159){ref-type="fig"}). The basal damaged blood vessels and collecting systems were continuously sealed with 2--0 absorbable sutures and the surgical wounds were continuously sealed with 1--0 absorbable sutures, using a Weck Hem-o-lok clip (Teleflex, Morrisville, NC, USA) to maintain the tension of the sutures. The Bulldog clamps were released, a lack of bleeding from the wound was confirmed and the blood supply of the kidney returned to normal. A drain was left following the surgery. The arterial occlusion time, surgical duration, intraoperative bleeding volume, post-operative drainage volume, pathological results, complications and post-operative follow-up results were recorded.

All the tumor specimens collected from the surgery were embedded in paraffin, sectioned and stained with hematoxylin and eosin (HE). The pathological subtypes of renal cell carcinoma were observed and analyzed by two professional pathologists, using HE staining.

Results
=======

### Surgery

All 31 patients were operated on successfully and no cases were converted to open surgery. The surgical duration was 80--120 min (mean, 95.5±27.1 min) and the arterial occlusion times were 15--30 min (mean, 21.2±7.2 min). The average intraoperative bleeding volume was 55.7±18.9 ml, with a range of 30--150 ml, while the average post-operative drainage volume was 92.3±28.9 ml, with a range of 50--250 ml. The average post-operative length of hospital stay was 6.1±0.6 days, ranging from 5--7 days. No hemorrhage or urinary leakage was observed in any patients following the surgery ([Table II](#tII-ol-0-0-5159){ref-type="table"}).

### Post-surgery

The post-operative pathological results indicated that 27 cases were diagnosed with suprarenal epithelioma, 2 with chromophobe cell renal carcinoma, 1 with oxyphilic adenoma and 1 with a juxtaglomerular cell tumor. The post-operative TNM staging revealed that 28 patients possessed T1a stage tumors and 3 patients possessed stage T1b tumors. The Fuhrman classification ([@b7-ol-0-0-5159]) was used to classify 15 patients with level 1, 8 cases with level 1--2 and 8 cases with level 2 RCC. All tumor specimens that were removed were wedge-shaped. The tumors were well circumscribed with negative margins. Following discharge from the hospital, all patients were followed up for 8--28 months (mean, 18.5±1.6 months) and no signs of local recurrence or distant metastases were identified by renal ultrasound or computed tomography examinations.

Discussion
==========

Radical nephrectomies may lead to renal decompensation. Therefore, for patients who have kidney ailments, which may endanger renal function, or renal tumors at the T1a clinical stage, LNSS is the recommended surgery ([@b8-ol-0-0-5159]). The core technologies of LNSS include controlling the warm ischemia time, guaranteeing a negative margin and avoiding the occurrence of secondary bleeding and urine leakage ([@b5-ol-0-0-5159]). Continuous research and improvements have been developed for these surgical aspects, including suture techniques, renal hypothermia protection technology, hemostatic materials and ureteral stents ([@b9-ol-0-0-5159]--[@b12-ol-0-0-5159]). These beneficial improvements ensure that LNSS is continuously improved and developed, and the clinical applications of LNSS are expanding.

The direction of the laparoscopic operative channel limits the surgery, and certain disadvantages remain unavoidable, including the narrow operative space. Occasionally, the cutting position is not visible and judging the base of the tumor is challenging, which may result in cutting more renal tissue or cutting into the tumor. Therefore, certain cases require surgeons with increased surgical experience and no standard exists to aid the judgment of the anatomical base of the tumor ([@b13-ol-0-0-5159]). At present, incisions with an ultrasound knife or sharp cuts with scissors are in common use in LNSS, which may easily damage the tumor capsule. In order to prevent the recurrence of a tumor following the partial nephrectomy of renal tumors, tumors have always been cut along the normal tissue to guarantee a negative margin ([@b14-ol-0-0-5159]). Through the investigation of multiple centers, a study conducted by Breda *et al* indicated that 21/855 (2.46%) patients who received LNSS had a positive margin ([@b15-ol-0-0-5159]). Urinary leakage is the major complication following LNSS, and dealing with the collecting system may extend the surgery and the warm ischemia time; therefore, doctors are required to be skilled in the associated surgical techniques. Effectively closing the collecting system during surgery may greatly decrease the possibility of urinary leakage post-operatively ([@b16-ol-0-0-5159]).

The renal parenchyma is composed of the renal cortex and the renal medulla, in a 1:2 ratio. Renal tumors grow in the renal parenchyma under the renal capsule and show inflated growth. Renal tumors continuously squeeze the surrounding renal parenchyma to form a pseudocapsule, and traditionally, the excision of renal tumors is always performed along the pseudocapsule. The renal capsule is composed mainly of fibrous tissue, and the renal cortex consists of a number of renal corpuscles, which are dense ([@b17-ol-0-0-5159]). The renal medulla includes numerous straight renal tubules that are arranged radially to form the medullary ray and the renal pyramids. Renal pyramids and the corresponding renal cortex are composed of renal lobules. The majority of the straight arterioles of the renal medulla are parallel to the long axis of the renal pyramids ([@b18-ol-0-0-5159]). The amplification effects of the laparoscope allow the easy identification of these precise anatomical structures.

In the present study, subsequent to cutting the renal capsule and renal parenchyma, the separation of the tumor from the reserved medullary and medullary ray was performed to the depth of the basement membrane, which is a simple procedure. The tumor was isolated with visible supplying blood vessels in 27 cases. The blood vessels were cut following the hemostasis of the region using bipolar coagulation, the wounds of which were simple to suture and possessed a low possibility of bleeding. In addition, for the central type of renal tumor, or 'H' in the R.E.N.A.L. nephrometry scoring system, the tumors are recommended to be stripped along the renal medulla to the renal sinus, subsequent to opening the renal cortex, in order to avoid the accidental injury of the renal artery and vein ([@b19-ol-0-0-5159]). The tumors of 3 patients with the central type of renal tumor in the present study were removed completely, and the renal artery and vein were not damaged; therefore, this method may also be applied to the treatment of central-type renal tumors. Urine collecting systems include the minor renal calyces, renal calyces, renal pelvis and ureteropelvic junction. The renal parenchyma encompasses the minor renal calyces, renal calyces and the majority of the renal pelvis. A renal calyx is composed of 2 or 3 minor renal calyces. Carefully stripping the base of the tumor may prevent the injury of the minor renal calyces ([@b20-ol-0-0-5159]). Fine processing of the blood vessels, renal medulla and minor renal calyces may also decrease the flow of blood from the surface of the wound, which reveals the structure clearly and provides a good view for the suturing. Therefore, the arterial occlusion times of the surgery reported in the present study were similar compared with previous reports in the literature.

Our preliminary experience of using the present method indicated the following features: i) The integrity of the tumor may be guaranteed during treatment for deep and basal tumors. Since the surgery was performed along the separated medullary space, the tumor was protected and the excision of excessive renal tissue was avoided. ii) Blood vessels that supply the tumor may be isolated and treated separately in order to decrease the risk of secondary bleeding. iii) The minor renal calyces may be isolated and treated separately to decrease the possibility of urinary leakage. Overall, the improved LNSS for RCC, based on the precise anatomy of the nephron, allows the excision of renal tumors according to the renal lobules and renal pyramids. The surgery ensures the complete resection of the tumor without the removal of excessive renal tissue and has the effect of precisely excising the tumor and the accumulating nephron. The LNSS method is simple, easy to master, and has the advantages of a low positive margin rate and fewer post-operative complications. In addition, the warm ischemia time was not increased during surgery, which may protect renal function to a greater extent, and the method is suitable for promoting for clinical use. The short-term treatment effects of the surgery are satisfactory, but the long-term effects require additional large prospective, randomized controlled studies to confirm the success of LNSS.

![Separation of the tumor and reserved medullary. Following the incision of the renal parenchyma, scissors with blunt and sharp edge were used to separate the base of the tumor from the normal renal medulla, in the direction of the ray medullary in the renal pyramids.](ol-12-05-3799-g00){#f1-ol-0-0-5159}

![Clear straight arterioles at the base of the kidney.](ol-12-05-3799-g01){#f2-ol-0-0-5159}

![Wound with clear anatomical structure following the stripping of the minor renal calyces.](ol-12-05-3799-g02){#f3-ol-0-0-5159}

###### 

Clinical comparison of patient features between the groups.

  Feature                                                                     Improved group (n=56)   Control group (n=36)   P-value
  --------------------------------------------------------------------------- ----------------------- ---------------------- ---------
  Age, years^[a](#tfn1-ol-0-0-5159){ref-type="table-fn"}^                       54.1±13.2               52.3±10.7            0.46
  Male gender, n (%)                                                          35 (62.5)               23 (63.9)              0.80
  BMI^[a](#tfn1-ol-0-0-5159){ref-type="table-fn"}^                            22.3±1.2                23.3±1.6               0.93
  Tumor diameter, cm^[a](#tfn1-ol-0-0-5159){ref-type="table-fn"}^               3.1±0.7                 3.4±1.1              0.56
  Affected side, n (%)                                                                                                       
    Left                                                                      25 (44.6)               15 (41.7)              0.67
    Right                                                                     31 (55.4)               21 (58.3)              0.38
  Location                                                                                                                   
    Upper pole                                                                20 (35.7)               14 (38.9)              0.57
    Middle                                                                    22 (39.3)               12 (33.3)              0.34
    Inferior pole                                                             14 (25.0)               10 (27.8)              0.76
  R.E.N.A.L.^[a](#tfn1-ol-0-0-5159){ref-type="table-fn"}^                       6.9±1.1                 6.6±0.8              0.75
  GFR prior to surgery, ml/min^[a](#tfn1-ol-0-0-5159){ref-type="table-fn"}^   45.6±6.4                47.6±7.4               0.89

Data are expressed as mean ± standard deviation. BMI, body mass index; GFR, glomerular filtration rate; R.E.N.A.L., R.E.N.A.L. nephrometry score, as determined by radius, exophytic/endophytic properties, nearness of tumor to the collecting system or sinus, anterior/posterior and location to relative polar lines.

###### 

Comparison of clinical data subsequent to surgery.

  Feature                         Improved group (n=56)   Control group (n=36)   P-value
  ------------------------------- ----------------------- ---------------------- ---------
  Arterial occlusion time, min    21.2±7.2                20.1±5.7               0.96
  Surgical duration, min            95.5±27.1               90.5±21.3            0.47
  Intraoperative bleeding, ml       55.7±18.9               63.5±20.1            0.53
  Post-operative drainage, ml       92.3±28.9             112.3±34.5             0.16
  Length of hospital stay, days     6.1±0.6                 6.9±0.9              
  Pathological types, n (%)                                                      
    CCE                           51 (91.1)               31 (86.1)              0.48
    Other                         5 (8.9)                   5 (13.9)             0.11
  Negative margin, %              100.0                   88.9                   \<0.01
  Complications, n                                                               
    Bleeding or urine leakage     0                       5                      \<0.01
    Other                         5                       5                      0.13
  GFR, ml/min                     14.32±2.12              16.17±2.34             0.34
  1-year recurrence rate, %         0.0                     2.8                  0.76

CCE, clear-cell carcinoma; GFR, glomerular filtration rate.
